To The Moon

While the healthcare sector has underperformed the broader market in recent years, there are still plenty of stocks with long-term investment value within the industry. $Regeneron Pharmaceuticals(REGN)$ , a leading enterprise in the biotech space, is well-positioned to outperform the market over the next decade, backed by its core product strengths and a robust research and development (R&D) pipeline. Core Growth Driver Maintains Strong Momentum Dupixent currently stands as the company’s most critical product driving revenue growth. Co-developed with Sanofi, this drug has been approved for indications such as atopic dermatitis and holds a leading position in its therapeutic areas. In 2024, Dupixent achieved a major milestone with the approval

Seeking out stocks trading well below analysts’ average target prices is often an effective way to uncover potential new additions to an investment portfolio. Investors should certainly not rush into buying based solely on this metric and need to conduct further in-depth research. Yet using it as a starting point for screening can help you quickly zero in on targets poised for substantial gains in the future. Wall Street is currently quite bullish on two stocks: $IONQ Inc.(IONQ)$ and $SoundHound AI Inc(SOUN)$ . Analysts covering IonQ have set an average target price of $74.89 for the stock, which is currently trading at around $33.30. This translates to a staggering potential upside of 125% based on the t

The US stock market has been trapped in a weak and volatile trend since 2026, with the S&P 500 Index posting a cumulative decline of 1% year to date as of Monday’s close. Beneath the surface of the overall market slump, however, a batch of deeply corrected stocks has quietly entered analysts’ buy radars. After a three-tier screening of 54 S&P 500 components that have fallen more than 20% this year, analysts identified 10 potential targets that combine valuation advantages, growth prospects and institutional consensus. Three hard screening criteria were set for this selection: Relative valuation advantage: Forward price-to-earnings (P/E) ratio, based on earnings estimates for the next 12 months, below the industry average; Superior growth potential: Expected 2-year compound annual g

The silver market staged a heart-stopping rollercoaster ride in 2026: amid extreme volatility, silver prices soared to an all-time high of $120 per ounce before plummeting sharply to the mid-$70 range. As a unique precious metal with both industrial and financial attributes, silver's performance is driven not only by industrial demand from sectors such as solar energy and electric vehicles but also by interest rates, inflation expectations and market sentiment. Compared with gold, silver's higher volatility makes it one of the most dynamic assets in the commodity market. Looking ahead to 2026-2030, persistent supply shortages and growing global demand are expected to drive a gradual climb in silver prices, potentially challenging the $145 mark. However, short-term fluctuations are inevitab

Vancouver, British Columbia– Scottie Resources Corp.  $SCOTTIE RES CORP.(SCTSF)$ (FSE: SR80) (“Scottie” or the “Company“) is pleased to report final assays from its 2025 drilling of various zones within the Blueberry Contact Zone, at the Scottie Gold Mine Project (“Scottie Gold Mine” or the “Project”). The road-accessible Project is located 35 kilometres north of Stewart, BC, and is the subject of a newly released Preliminary Economic Assessment (“PEA”) entitled Scottie Gold Mine Project (Bird et al., October 28, 2025, Scottie Gold Mine Project, SEDAR+). In 2025, Scottie completed its biggest drill season ever, drilling more than 27,300 metres across 126 holes. This included 17 specialized holes (2,300 metres) focused on ground stabilit

Hi, Tigers 🐯 Despite ongoing cost pressures, the healthcare sector’s growth outlook remains constructive. An ageing population and continued breakthroughs in medical innovation continue to provide long-term support Looking to invest in this sector but don’t wanna pick individual stocks? ETFs offer a simple and cost-efficient way to gain exposure! Of course, near-term challenges are real.According to a McKinsey report dated 12 January, the US healthcare system is under increasing financial pressure. Industry operating margins are expected to fall from 11.2% in 2019 to 8.9% in 2024, with payers and healthcare providers most affected. However, analysts expect conditions to improve gradually over the next three years.With an ageing population and steady demand for new therapies, healthcare rem

Silver is shining, but a rarer, more strategic metal is grabbing the spotlight: Uranium. As Artificial Intelligence (AI) drives a global power surge, nuclear fuel is preparing for a massive breakout. Uranium prices have already cleared $90/lb, hitting multi-year highs. Unlike gold or silver, uranium is traded via private, long-term contracts. This low transparency means that when supply runs thin, prices can skyrocket fast. 1. 🚀 3 Reasons Why Uranium is Surging The AI Revolution ⚡ AI needs massive, 24/7 power. Wind and solar are too intermittent. Nuclear is the only carbon-free source that provides stable "always-on" energy. Tech giants like $Microsoft(MSFT)$ , $Amazon.com(AMZN)$ , and

As the IPO market gradually recovers in 2025, global investors have turned their attention to 2026, a year that could define the next decade. Among the many emerging tech giants rumored to be going public, two names consistently dominate the headlines: SpaceX, the space exploration company founded by Elon Musk, and OpenAI, the AI revolution spearheaded by Sam Altman. They are not only symbols of cutting-edge technology but also have the potential to become the largest IPOs in history. If both companies do go public in the same year, how should investors choose? 🚀 SpaceX: Packing the Interstellar Future into its Prospectus Founded in 2002 by serial entrepreneur Elon Musk, SpaceX aims to reduce launch costs through reusable rocket technology, with the ultimate goal of achieving travel to the

As the legendary era of the "Oracle of Omaha," Warren Buffett, draws to a close, his successor, Greg Abel, has officially been CEO of Berkshire Hathaway $Berkshire Hathaway(BRK.A)$ for just a month. Yet, a major move seems to be quietly brewing—one that could signal a rewrite of the company's long-standing investment philosophy. Recently, a regulatory filing stirred the market like a stone thrown into a calm lake: Berkshire may be preparing to sell its entire stake in Kraft Heinz $The Kraft Heinz Company(KHC)$ . Could this be the first defining moment of the "Post-Buffett Era"? ⚠️ An Unusual Risk Warning On Tuesday, food giant $The Kraft Heinz Company(KHC)$ incl

Since the start of 2025, the silver market has staged a spectacular rally. By the end of December 2025, silver prices had accumulated a staggering gain of approximately 171%. During the session on December 26, prices briefly touched a high of $80 per ounce before closing the year at around $72. Entering 2026, $iShares Silver Trust(SLV)$ continues to lead the commodities pack, emerging as the brightest performing asset in the Bloomberg Commodity Index. Meanwhile, the Gold-Silver Ratio—which measures how many ounces of silver it takes to buy one ounce of gold—has rapidly slid from recent highs to around 57. This is not only far below the long-term average of 68 but also marks a new low since 2013, signaling a strong "catch-up" momentum for silver rel